Home NDC 65862-709-39 Raloxifene Hydrochloride
Product NDC 65862-709
Requested package NDC 65862-709-39
11-digit product format 658620709
Labeler code 65862
Product ID 65862-709_161df518-c043-4476-968b-d0268ae03fd5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Raloxifene Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA204310
Marketing category ANDA
Marketing start 2015-08-28
Substance RALOXIFENE HYDROCHLORIDE
Active strength 60 mg/1
Pharmacologic classes Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A204310-001 RALOXIFENE HYDROCHLORIDE RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2015-08-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A204310-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A204310-001 RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2015-08-28 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 A204310-001 AB 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE A-S Medication Solutions 804e873e-f48b-4c25-ad7b-41d44f61bdde 2025-11-06 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 204310 application number: ANDA204310 Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE Bryant Ranch Prepack 5a22ae27-1c55-487b-8e93-8ef1cec87065 2024-04-03 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 204310 application number: ANDA204310 Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE NorthStar Rx LLC 0f7d1f81-374f-4ad5-aea0-2f97abbe1dbf 2024-02-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 204310 application number: ANDA204310 Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE Aurobindo Pharma Limited e8b6cbe0-c1f4-4678-b852-f629a7f6a1b5 2024-02-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 204310 application number: ANDA204310 ndc (product): 65862-709
Additional Listing Data#
Finished product Yes
Brand name base Raloxifene Hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RALOXIFENE HYDROCHLORIDE 60 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4F86W47BR6 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1490065 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65862-709-01 Raloxifene Hydrochloride 100 in 1 BOTTLE TABLET, FILM COATED 100 7 65862-709-03 Raloxifene Hydrochloride 3 in 1 CARTON TABLET, FILM COATED 3 7 65862-709-10 Raloxifene Hydrochloride 10 in 1 BLISTER PACK TABLET, FILM COATED 10 7 65862-709-22 Raloxifene Hydrochloride 2000 in 1 BOTTLE TABLET, FILM COATED 2000 7 65862-709-30 Raloxifene Hydrochloride 30 in 1 BOTTLE TABLET, FILM COATED 30 7 65862-709-99 Raloxifene Hydrochloride 1000 in 1 BOTTLE TABLET, FILM COATED 1000 7
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RALOXIFENE HYDROCHLORIDE ACTIVE INGREDIENT 4F86W47BR6 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 RALOXIFENE ACTIVE MOIETY YX9162EO3I RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 HYPROMELLOSE 2910 (5 MPA.S) INACTIVE INGREDIENT R75537T0T4 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 POVIDONE K30 INACTIVE INGREDIENT U725QWY32X RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65862-709 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 7 Current NDC, Legacy NDC, 6 package rows 20240220_e8b6cbe0-c1f4-4678-b852-f629a7f6a1b5.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Status 65862-709-39 65862070939 3000 TABLET, FILM COATED in 1 BAG (65862-709-39) 28-AUG-15 Current